GlassScriptPhysician profile
Stanley Lawrence Hoy
NPI 1043660228
$45,293.37
in general payments reported to CMS, 2019-2025
28 companies · $38K in 2025
The $38K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $91.62 · 2021: $48.96 · 2022: $1,936 · 2023: $98.38 · 2024: $4,940 · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $2,791 · Travel and Lodging: $2,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $34,668.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $2,791.46 |
| Travel and Lodging | $2,427.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $41,615.02 | 2022-2025 | |
| Pinnacle Biologics, INC | $1,794.01 | 2022-2025 | Photofrin |
| United Therapeutics Corporation | $205.85 | 2019-2024 | Tyvaso |
| Abiomed | $144.85 | 2024 | Impella |
| Pulmonx Corporation | $140.81 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Siemens Medical Solutions USA, INC. | $138.49 | 2024 | |
| Galvanize Therapeutics, INC | $137.15 | 2024 | Aliya System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.16 | 2024-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $126.63 | 2025 | Nucala |
| Acelrx Pharmaceuticals, INC. | $101.44 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Medtronic Vascular, INC. | $91.62 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $75.01 | 2024-2025 | Breztri, Fasenra |
| Takeda Pharmaceuticals U.S.A., INC. | $67.25 | 2024-2025 | Glassia |
| Merck Sharp & Dohme LLC | $59.79 | 2024-2025 | Zerbaxa, Dificid, Recarbrio |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $58.82 | 2025 | Yupelri |
| Ambu INC. | $56.33 | 2023 | |
| Insmed, INC. | $55.25 | 2021-2025 | Brinsupri, Arikayce |
| Ani Pharmaceuticals, INC. | $36.96 | 2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $29.82 | 2022 | |
| Amgen INC. | $23.07 | 2023 | Tezspire |
| Grifols USA, LLC | $20.51 | 2024 | Prolastin-C Liquid |
| Olympus America INC. | $18.98 | 2023 | Spiration Valve System |
| Genzyme Corporation | $17.34 | 2025 | |
| Philips North America LLC | $14.46 | 2025 | Vest Therapy Und |
| Erbe USA INC | $14.28 | 2024 | |
| Janssen Pharmaceuticals, INC | $12.63 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Hoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.